Julie Massayo Maeda Oda

CXCL12 rs1801157 polymorphism in patients with breast cancer, hodgkin's lymphoma, and non‐hodgkin's lymphoma

Karen Brajão de Oliveira, Julie Massayo Maeda Oda, Júlio César Voltarelli et al. · Journal of Clinical Laboratory Analysis · 2009 · 42 citations

Life Sciences, Molecular Biology, Molecular Genetics +17

CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients

Karen Brajão de Oliveira, Roberta Losi Guembarovski, Julie Massayo Maeda Oda et al. · Cytokine · 2011 · 32 citations · Full text

Life Sciences, Genetics, Oncology +14

<i>FOXP3 Transcription Factor</i>: A Candidate Marker for Susceptibility and Prognosis in Triple Negative Breast Cancer

Leandra Fiori Lopes, Roberta Losi Guembarovski, Alda Losi Guembarovski et al. · BioMed Research International · 2014 · 26 citations · Full text

Life Sciences, Genetics, Oncology +10

CXCL12 and TP53 genetic polymorphisms as markers of susceptibility in a Brazilian children population with acute lymphoblastic leukemia (ALL)

Aparecida de Lourdes Perim, Roberta Losi Guembarovski, Julie Massayo Maeda Oda et al. · Molecular Biology Reports · 2013 · 24 citations

Medicine, Genetics, Molecular Genetics +14

The effect of propolis on CCL5 and IFN-<i>γ</i> expression by peripheral blood mononuclear cells from leishmaniasis patients

Marla Karine Amarante, Maria Angélica Ehara Watanabe, Ivete Conchon‐Costa et al. · Journal of Pharmacy and Pharmacology · 2011 · 23 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17